Thomas Stankovich, CFO at ReShape Lifesciences Inc. (RSLS), sold 8,293 shares at $0.28 ($2K) on 2022-10-04, disclosed to the SEC on 2022-10-06.
Open-market sale of $2k RSLS by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.28 | 2,484 | $696 | 30.0% |
| 2 | $0.28 | 5,809 | $2K | 70.0% |
| Total | $0.28 avg | 8,293 | $2K | 100% |
| Filing → |
| RSLS | SELL | 2023-07-19 | $156 | — | Filing → |
| RSLS | BUY | 2023-07-06 | $27K | — | Filing → |
| RSLS | SELL | 2023-07-06 | $746 | — | Filing → |